Alexandra Tolia

Alexandra Tolia possesses extensive experience in the biotechnology and pharmaceutical sectors, currently serving as a Board Member at Rewind Therapeutics and holding a position as a Member of the European Expert Group on Orphan Drug initiatives with OD Expert Group. Alexandra has also taken on roles such as Strategic Advisor at PMV and previously held several board positions at organizations including ONA Therapeutics, Confo Therapeutics, EPICS Therapeutics, eTheRNA immunotherapies, and FundPlus. Educational qualifications include a PhD in Medical Sciences from KU Leuven, a Diploma in Biology from Kapodistriako University of Athens, and a General Management degree from the Solvay Brussels School of Economics and Management.